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Lantibiotics are lanthionine-containing peptide anti-
biotics. Nisin, encoded by nisA, is a pentacyclic lantibi-
otic produced by some Lactococcus lactis strains. Its
thioether rings are posttranslationally introduced by a
membrane-bound enzyme complex. This complex is
composed of three enzymes: NisB, which dehydrates
serines and threonines; NisC, which couples these dehy-
drated residues to cysteines, thus forming thioether
rings; and the transporter NisT. We followed the activity
of various combinations of the nisin enzymes by meas-
uring export of secreted peptides using antibodies
against the leader peptide and mass spectroscopy for
detection. L. lactis expressing the nisABTC genes effi-
ciently produced fully posttranslationally modified pre-
nisin. Strikingly, L. lactis expressing the nisBT genes
could produce dehydrated prenisin without thioether
rings and a dehydrated form of a non-lantibiotic pep-
tide. In the absence of the biosynthetic NisBC enzymes,
the NisT transporter was capable of excreting unmodi-
fied prenisin and fusions of the leader peptide with non-
lantibiotic peptides. Our data show that NisT specifies a
broad spectrum (poly)peptide transporter that can func-
tion either in conjunction with or independently from
the biosynthetic genes. NisT secretes both unmodified
and partially or fully posttranslationally modified forms
of prenisin and non-lantibiotic peptides. These results
open the way for efficient production of a wide range of
peptides with increased stability or novel bioactivities.
A wide spectrum of biological functions, such as hormone,
growth factor, enzyme inhibitor, antigen, antibiotic, and iono-
phore, can be found among peptides. Cyclization of peptides
has been shown to be a valuable method to obtain biostable
analogs. Furthermore, by conformational constraints, en-
hanced or modulated receptor interaction can be obtained (1,
2). Thioether rings can contribute to enhanced peptide stabil-
ity, enhanced resistance against proteolytic degradation (3, 4),
and modulation of receptor interaction (2).
Lantibiotics are bacterial peptides with intramolecular
thioether bridges (5). They owe their name to their antibiotic
activities and the presence of lanthionine residues. Lanthioni-
nes are thioether-containing amino acids. A variety of activities
have been demonstrated for lantibiotics, e.g. the autoinduction
of lantibiotic synthesis (6), permeabilization of target mem-
branes (7–11), inhibition of cell wall synthesis (12), lipid II
binding (13), inhibition of phospholipase A2 (14), and modula-
tion of autolytic enzymes (15) and of an angiotensin-converting
enzyme (16). These activities all depend on the presence of
thioether rings. By controlling the lanthionine-synthesizing
enzyme complex, one might envisage the possibility of intro-
ducing thioether rings at any peptide position. However, at
present, only one new thioether ring has been synthesized in
a lantibiotic (3). Most interestingly, in vitro activity of the
lanthionine-synthesizing enzyme LctM has recently been
demonstrated (17).
The best known lantibiotic is nisin, which is produced by
some Lactococcus lactis strains. Nisin is widely applied as a
food preservative (18) because of its antimicrobial activity. It
displays a variety of antibiotic activities against many Gram-
positive bacteria (7, 19). Breukink et al. (13) found that nisin
interacts with lipid II of the target cell and, already at very low
concentrations, this complex permeabilizes the membranes for
small ions and solutes.
Nisin is composed of 4 methyllanthionines, 1 lanthionine, 2
dehydroalanines, 1 dehydrobutyrine, and 26 unmodified amino
acids (20, 21). At position 33, mostly a dehydroalanine is pres-
ent, but in some cases, an unmodified serine can be found (22).
The above-mentioned uncommon residues are posttranslation-
ally produced by intracellular membrane-associated enzyme
complexes (23, 24). The enzyme NisB dehydrates serines and
threonines; NisC is responsible for thioether bridge formation
by coupling the dehydro residues to cysteines, and NisT exports
fully modified prenisin. The extracellular serine protease NisP
cleaves off the N-terminal 22–23 amino acid leader peptide
(with or without initiating methionine), whereupon the active
nisin is released (Fig. 1).
Here we show that the nisin-precursor transporter NisT, in
different combinations with NisB and NisC, is able to transport
a wide variety of modified and unmodified peptides. This now
opens the way to the biotechnological production of modified
peptides with novel bioactivities and improved stability. More-
over, we show that the processing enzyme, NisP, requires lan-
thionine formation of the propeptide for proper functioning.
MATERIALS AND METHODS
Leader Peptide—A synthetic leader peptide without initiating methi-
onine was purchased from Synpep, Dublin, CA. Bacterially produced
leader peptide was purified by binding to Teflon beads, a C18 column,
and elution with an acetonitrile gradient. Cleavage of leader peptide
from fully modified prenisin resulted from a 15-min incubation at 37 °C
with 1 mg/ml trypsin.
Anti-leader Peptide Antibodies—Polyclonal antibodies were raised in
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rabbits against the peptide H2N-STKDFNLDLVSVSKKDC-CONH2
coupled via the cysteine to keyhole limpet hemocyanin. Samples for
Western blotting were prepared as follows. Ten ml (20 ml for samples
from cells with pLP1vp and pLP1ang) of bacterial culture supernatant
was precipitated with 10% trichloroacetic acid, kept on ice for 2 h,
pelleted by centrifugation at 18,514  g during 30 min at 4 °C, washed
with 10% trichloroacetic acid and with acetone, and vacuum-dried.
Pellets were dissolved in 50 l (for TP9703, NZ9700, and PA1001
containing pBMDL5) or 20 l of sample buffer and applied on a gel.
Bacterial Strains and Plasmids—Strains and plasmids are listed in
Table I. L. lactis strains PA1001 and TP9703 were prepared from
NZ9000 and NZ9700, respectively, using the pOri gene replacement
system (29). In TP9703, the nisP start codon of NZ9700 was replaced by
a NotI restriction site.
Molecular Cloning—Nisin gene(s) (combinations) were amplified
from chromosomal DNA of L. lactis NZ9700. DNA amplification was
carried out using Expand high fidelity polymerase (Roche Applied Sci-
ence) or Pfu polymerase (Invitrogen), in the case of insertion or deletion
via round-PCR. Plasmid DNA was isolated using the Roche Applied
Science kit. DNA was restricted using restriction enzymes from New
England BioLabs Inc. Ligation was carried out with T4 DNA ligase
(Roche Applied Science). DNA fragments were isolated from agarose gel
using the Zymoclean gel DNA recovery kit (Zymo Research, Orange,
CA) or from a PCR mix by using the Roche Applied Science PCR
purification kit. For intermediate cloning steps, pGEM-T (Promega)
was used. Transformation of Escherichia coli (E. coli DB3.1 (ccdB mu-
tant); E. coli DH5 and E. coli TOP10, all obtained from Invitrogen) was
carried out using established procedures (30). Electrotransformation of
L. lactis was carried out as described previously (31) using a Bio-Rad
Gene Pulser (Bio-Rad). Nucleotide sequence analyses were performed
by BaseClear (Leiden, The Netherlands).
Culturing—L. lactis was grown in M17 broth (32) supplemented with
0.5% glucose (MG17) with or without chloramphenicol (5 g/ml) and/or
erythromycin (5 g/ml). E. coli was cultured in trypton-yeast medium
with or without ampicillin (100 g/ml) or erythromycin (100 g/ml).
Preceding mass spectrometry, cells were cultured, and samples were
prepared as follows. Overnight cultures of L. lactis grown in MG17
broth were diluted 1/100. At an optical density at 660 nm of 0.4, cells
were centrifuged, and the medium was replaced by minimal medium
(33) with or without 1/1000 volume of filtered (0.4 m) overnight
L. lactis NZ9700 culture medium containing nisin. Incubation was
continued for 4 h or overnight, after which mass spectrometry samples
were prepared. In the case of cells containing pNGnisBT, 50 ml of
medium was subjected to trichloroacetic acid precipitation prior to
further analysis. Growth inhibition experiments were performed as
described previously (34) but in the absence of Tween.
Mass Spectrometry—Samples were obtained by ZipTip purification
(C18 ZipTip, Millipore). ZipTips were wetted and equilibrated with 50%
acetonitrile followed by demineralized water. Then peptides were
bound and washed with demineralized water, eluted with a solution of
0.1% trifluoroacetic acid with 30 or 50% acetonitrile, vacuum-dried, and
stored at 20 °C until analysis. The dried ZipTip eluent was resus-
pended in 50% acetonitrile containing 0.1% (v/v) trifluoroacetic acid,
and 1 l was applied to the target. Subsequently, 1 l of matrix (10
mg/ml -cyano-4-hydroxycinnamic acid completely dissolved by mildly
heating and vortexing in 50% acetonitrile containing 0.1% (v/v) triflu-
FIG. 1. Posttranslational modifica-
tions of prenisin. 1, serines and threoni-
nes of unmodified prenisin are dehydrated
by NisB. 2, the resulting dehydrated pre-
nisin contains dehydroalanines (Dha) and
dehydrobutyrines (Dhb). 3, NisC forms
thioether rings between dehydrated resi-
dues and cysteines resulting in fully mod-
ified prenisin. 4, NisT transports the fully
modified prenisin, and NisP cleaves off
the leader peptide liberating nisin.
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oroacetic acid) was added to the target and allowed to dry. Mass spectra
were recorded with a Bruker Biflex III MALDI-time-of-flight mass
spectrometer. To maintain high sensitivity, an external calibration was
applied. Ethanethiol treatment (35) was applied to confirm posttrans-
lational modification.
Measurement of Leader Peptidase Specificity—NisP-mediated cleav-
age of peptides was measured by MALDI-TOF1 MS. Log phase L. lactis
strains were induced during 4 h or overnight. In the indicated cases,
NisP-mediated cleavage was measured after pH-induced ring closure.
Ring closure in dehydrated prenisin was achieved by a 1-h incubation at
pH 8.0, which was followed by readjustment of the pH to 4.3. Treatment
of peptide-containing supernatant with cells of NZ9000 containing
pNGnisTP was performed during 4 h followed by MALDI-TOF MS
analysis.
Induction Assay—The presence of nisin was also tested using the
sensitive GusA assay (6) that monitors the capacity of nisin to induce
the nisin promoter.
RESULTS
Detection of the Nisin Leader Peptide—We first investigated
whether the nisin leader peptide would remain present in the
culture medium of a nisin-producing L. lactis NZ9700 strain.
Peptides isolated from the supernatant of this strain reacted
with anti-leader peptide antibodies (Fig. 2, lane 3). A Coomass-
ie-stained gel of a C18 column elution fraction showed the
presence of peptide (Fig. 3A) with a mass of 2350.9 Da (MALDI-
TOF MS). An identical peptide (Fig. 3B) was observed when
ZipTip-treated supernatant from a nisin-producing L. lactis
NZ9700 strain, grown overnight in minimal medium (33), was
analyzed via mass spectrometry. This mass corresponds to the
nisin leader peptide without the initiating methionine. In ad-
dition, peaks with masses corresponding to the nisin leader
peptide with the initiating methionine (2482.2 Da) and nisin
(3354.2 Da) were detected (Fig. 3B). In control incubations with
L. lactis strain NZ9000, which does not produce nisin, no peaks
were observed. A synthetic leader peptide of residues 2–23 gave
a mass peak identical to the peak we assigned to the cleaved
leader peptide without the initiating methionine. These data
for the first time demonstrated the presence of intact nisin
leader peptide in the culture medium following secretion
and processing.
Thioether Ring Formation by NisBTC—To investigate
whether NisBTC are sufficient for thioether ring formation, we
cloned the nisABTC genes. Both uninduced (Fig. 2, lane 13) and
induced PA1001 (Fig. 2, lane 14) containing pBMDL5 produced
prenisin. Apparently, when no inducing nisin was added, some
transcription still occurred; this has also been reported previ-
ously for wild-type nisin producers (6). Subsequently, we ana-
lyzed the prenisin peptides. The uninduced strain PA1001 con-
taining pBMDL5 produced two peptides with masses
corresponding to dehydrated prenisin or fully modified prenisin
with and without the initiating methionine (5817.4 and 5686.5
1 The abbreviations used are: MALDI-TOF, matrix-assisted laser de-
sorption/ionization time-of-flight; MS, mass spectrometry.
TABLE I
Lactococcus lactis strains and plasmids
Strains and plasmids Characteristics Source/reference
NZ9700 nisABTCIPREFG, nisin producer Ref. 25
NZ9800 Derived from NZ9700 by disruption of nisA Ref. 21
NZ9743 Derived from NZ9700 by disruption of nisT Ref. 26
NZ9000 nisRK Ref. 25
PA1001 acmA (27), htrA (28), derived from NZ9000 This study
TP9703 nisP, derived from NZ9700 This study
pNZ8048 derived plasmids Ref. 25
pNGnisT nisT, Em-r a or Cm-r b This study
pNGnisTP nisTP, Em-r or Cm-r This study
pNGnisP nisP, Cm-r This study
pNZnisA-E3 nisA, Em-r This study
pLP1 The leader of nisin, Cm-r This study
pLP1ang An angiotensin-(1–7) variant (NRSYICP) behind the nisin leader, Cm-r This study
pLP1vp A vasopressin variant (SYFQNCPRG) behind the nisin leader, Cm-r This study
pNG-enkT An enkephalin variant (YTGFC) behind nisA, Em-r This study
pBMDL5 nisABTC in a gateway plasmid. An inverted repeat is present between nisA and
nisB as on the chromosome of NZ9700, Em-r
This study
pBMDL8b nisABT (S-6P, P-2L nisA) in a gateway plasmid. An inverted repeat is present
between nisA and nisB as on the chromosome of NZ9700, Em-r
This study
pNGnisBT nisBT, Em-r or Cm-r This study
a Em-r, erythromycin resistance gene.
b Cm-r, chloramphenicol resistance gene.
FIG. 2. Extracellular peptide detection by anti-leader peptide
antibodies. L. lactis cells were induced with nisin () or not induced
(), incubated for 4 h (NZ9000 containing pNGnisT and pLP1vp) or
overnight, and subjected to trichloroacetic acid precipitation and West-
ern blotting. Lanes 1 and 2, strain TP9703; lane 3 strain NZ9700; lanes
4 and 5, strain NZ9000 containing pNGnisT and pNGenkT; lanes 6 and
7, strain NZ9000 containing pNGnisT and pLP1vp; lanes 8 and 9, strain
NZ9000 containing pNGnisT and pLP1ang; lanes 10 and 11, strain
NZ9000 containing pNGnisT and pNZnisA-E3; lane 12, strain NZ9000
containing pBMDL8b; and lanes 13 and 14, strain PA1001 containing
pBMDL5. Each experiment was repeated at least three times with
similar results.
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Da) and a third peptide corresponding to unmodified prenisin
(5833.9 Da). Similar peptide masses were observed after the
induction of PA1001 containing pBMDL5 (Table II), but the
mass peak of dehydrated or fully modified prenisin (5688.9 Da)
was more pronounced.
The trypsin-treated supernatant of induced PA1001 contain-
ing pBMDL5 showed a growth-inhibiting activity comparable
with that of NZ9700, indicating the presence of fully modified
prenisin. Uninduced cells showed a much lower activity. In
addition, trypsin-treated culture medium of uninduced and
nisin-induced PA1001 cells containing pBMDL5 gained in in-
duction capacity as measured with the GusA assay (6).
The production of fully modified prenisin by PA1001 contain-
ing pBMDL5 was confirmed by overlaying agar plate cells with
NZ9000 (Fig. 4A) and with NZ9000 containing pNGnisTP (Fig.
4B). As expected, NZ9700 (position 2) produced clear halos with
both overlays, whereas PA1001 (position 1) did not form a halo.
By contrast, PA1001 containing pBMDL5 (position 3) and
TP9703 (position 4) only produced halos when overlaid with
NZ9000 containing pNGnisTP (Fig. 4B). Consistent with the
lower activity of trypsin-treated TP9703 supernatant, the halos
produced by TP9703 were much smaller than those of PA1001
cells containing pBMDL5. These data demonstrate that both
induced, and to a lesser extent, uninduced PA1001 cells con-
taining pBMDL5 produce fully modified prenisin, thus showing
that the NisBTC enzymes are sufficient for the thioether ring
formation.
Export of Dehydrated Prenisin via NisBT—Next, we investi-
gated the functionality of NisBT in the absence of NisC. Strik-
ingly, NZ9000 cells containing pBMDL8B produced prenisin
(Fig. 2, lane 12). Mass spectrometry analysis of the superna-
tant of these cells with plasmid-encoded NisABT (the nisA gene
of this construct having two leader peptide mutations, S -6 P
and P -2 L) demonstrated the production of dehydrated preni-
sin (5711.2 Da) and unmodified prenisin (5857.0 Da) (Table II).
This shows that NisBT can act independently of NisC and also
demonstrates that the NisT transport activity is not strictly
coupled to full posttranslational modification of prenisin.
Modification and Transport of a Non-lantibiotic Peptide—To
investigate whether fusions of the leader with a non-lantibiotic
peptide could be modified by NisB and transported by NisT,
peptide production by NZ9000 containing pNGnisBT and
pLP1ang, encoding a fusion of the leader peptide with NRSY-
ICP, was investigated. Both unmodified (3317.9 and 3186.5 Da)
and dehydrated fusions of leader peptide with angiotensin-
(1–7) (3302.9 and 3169.2 Da), with and without methionine 1,
were observed (Table II). To confirm the observed dehydration,
prior to analysis, the peptide samples were treated with
ethanethiol, which reacts with dehydro residues. Indeed, after
ethanethiol treatment, the peptide with the mass of dehy-
drated leader angiotensin-(1–7) had disappeared, whereas a
peptide corresponding to ethanethiol-modified dehydrated pep-
tide appeared (3235.6 Da). As expected, ethanethiol treatment
did not alter the mass of the non-dehydrated peptide (3188.6
Da). These data clearly prove that the fusion of leader peptide
with angiotensin-(1–7) was dehydrated and transported by
NisBT.
NisT Has a Broad Substrate Specificity—We subsequently
determined whether NisT, in the absence of NisBC, is capable of
transporting various unmodified fusion peptides containing the
nisin leader peptide. Experiments were performed with NZ9000
cells containing two plasmids, one coding for NisT and the second
for a leader peptide fusion. Export of unmodified prenisin (Fig. 2,
lane 11), unmodified prenisin with a C-terminally fused enkepha-
lin peptide (Fig. 2, lane 5), a fusion of the leader peptide with a
vasopressin variant (Fig. 2, lane 7), and a fusion of the leader
peptide with an angiotensin variant (Fig. 2, lane 9) was meas-
ured using anti-leader peptide antibodies. Mass spectra clearly
demonstrated export of unmodified prenisin without the initiat-
ing methionine (5833.2 Da), of a fusion peptide of unmodified
prenisin with a C-terminal enkephalin variant (6403.2 Da), of a
fusion of nisin leader peptide with vasopressin (3405.2 Da), and
of a fusion peptide of the nisin leader peptide with angiotensin-
(1–7) (3186.6 Da) (Table II). Control experiments without pNG-
nisT and with strain NZ9743 (26) containing disrupted nisT
showed no detectable levels of secreted peptide in the culture
medium. Furthermore, in the cell fraction of induced NZ9743
cells, an antibody-reactive peptide was detected (data not
shown). Taken together, the data clearly demonstrate that NisT
can act independently of the other lantibiotic enzymes and fur-
ther show that the substrate specificity of NisT is much wider
than only the fully modified prenisin.
NisP Is Specific for Thioether Ring-containing Prenisin—We
measured which leader peptide-containing peptides could be
cleaved by the leader peptidase. The leader peptide could nei-
ther be cleaved from the leader peptide-angiotensin fusion nor
be cleaved from the unmodified or dehydrated prenisin (Table
III). However, after keeping the dehydrated prenisin for 1 h at
pH 8.0, the leader peptide could be cleaved off. At pH 8.0,
thioether rings can be closed spontaneously (36, 37), after
which the peptide apparently had become substrate for the
leader peptidase. The pH 8.0- and NisP-treated dehydrated
prenisin had, however, no antimicrobial activity (data not
shown), which indicates that no fully modified prenisin had
been formed. Fully modified prenisin itself was also cleaved by
the leader peptidase, and a control experiment showed that, in
FIG. 3. Isolation of nisin leader pep-
tide from culture medium. A, leader
peptide isolated from L. lactis NZ9700
culture medium by binding to Teflon
beads and a C18 column was subjected to
gel electrophoresis and stained with Coo-
massie. B, detection of the nisin leader
peptide by MALDI-TOF MS. The super-
natant of overnight L. lactis NZ9700
grown on minimal medium was ZipTip-
treated followed by MALDI-TOF MS
analysis. Expected average masses
(MH) are: for the nisin leader peptide
residues 2–23, 2352.6 Da; for the nisin
leader peptide residues 1–23, 2483.8 Da;
for nisin, 3355.2 Da. The experiment
shown is a typical result that was re-
peated more than 10 times with identical
results.
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the absence of leader peptidase, the pH 8.0 treatment alone did
not liberate the leader peptide (Table III).
To discriminate between NisT-dependent- and -independent
NisP activity, a plasmid containing the nisP gene was con-
structed. An antimicrobial activity assay involving fully modi-
fied prenisin and mass spectrometry analysis confirmed that
the NZ9000 cells containing pNGnisP expressed active NisP as
they were able to cleave the leader peptide from externally
added fully modified prenisin (data not shown). Hence, NisP
can act independently of other lantibiotic enzymes.
DISCUSSION
The leader peptide of nisin may fulfill several functions.
First, prior to export, it may have a role in the posttranslational
modification and recognition events (17, 38). Second, it is
needed for recognition by the transport system, and third, it
keeps the lantibiotic in an inactive state until maturation has
taken place (4). Here, we demonstrated that the nisin leader
peptide accumulates in the bacterial culture medium of nisin-
producing L. lactis cells.
The subtilin leader peptide has been shown to act as a
translocation signal in Bacillus subtilis (39) and in E. coli (40).
The export of the alkaline phosphatase of E. coli when fused
with the subtilin leader peptide seemed to be enhanced in the
presence of a transporter that is encoded within the subtilin
operon (39). When the leader peptidase of subtilin is inhibited
by phenylmethylsulfonyl fluoride, accumulation of fully modi-
fied presubtilin, subtilin, and a series of degradation products
in the medium has been observed (41). Mutagenesis studies of
the leader peptide of various lantibiotics revealed that some of
the leader peptide residues are essential for export and possi-
bly for interaction with the modifying enzymes (42–44). In
contrast to the present work, it has also been suggested that
fully modified prenisin is the only form of nisin recognized by
the transporter (45).
A membrane-associated enzyme complex of NisBTC has
been reported to be responsible for dehydration of the serine
and threonine residues of prenisin, the thioether ring forma-
tion by cross-linking of dehydro residues to cysteines, and the
final export step (23). In nisin, Ser-29 is not dehydrated,
whereas Ser-33 sometimes escapes dehydration. Overexpres-
sion of NisB results in a more frequent dehydration of Ser-33
(22). Here we report that the genes nisABTC are sufficient for
production and export of fully modified prenisin. Strikingly, we
also demonstrate that NisB and NisT suffice to export dehydro
residue-containing peptides. This implies that ring formation is
not a prerequisite for export. Dehydrated prenisin is, however,
not a substrate for NisP, which indicates that further modifi-
cation is needed before NisP recognizes the prenisin as sub-
strate. Incubation of the dehydrated form of prenisin at pH 8.0
results in spontaneous ring closure (36, 37). Under those con-
ditions, the peptide becomes a substrate of NisP, and the leader
peptide can be cleaved off. L. lactis NZ9000 with NisABT but
without NisC indeed produced the dehydrated prenisin with
the dehydroalanines and dehydrobutyrines present and with-
out the ring closure. The serine and threonine residues in the
leader peptide are never dehydrated, as confirmed by mass
FIG. 4. Leader peptidase activity in NisP producing cells.
PA1001 (position 1), NZ9700 (position 2), PA1001 containing pBMDL5
(position 3), and TP9703 (position 4) cells were grown overnight on agar
plates that contained no antibiotic next to inducing amounts of nisin.
Subsequently, the cells were overlaid with log phase-grown sensitive
strain NZ9000 (A) and NZ9000 containing pNGnisTP (B) cells and
further grown for one more night. The size of the halo indicates the
presence of active nisin processed by NisP. The experiment was re-
peated three times in duplicate with similar result.
TABLE II
Modification and export of peptides in L. lactis
Cells were induced and grown 4 h (NZ9000 containing pNGnisT and pNGang, NZ9000 containing pNGnisT and pLP1vp) or overnight in minimal
medium followed by trichloroacetic acid precipitation and/or direct ZipTip treatment of the supernatant and MALDI-TOF MS. Experiments were
repeated at least three times with similar result. Theoretical values are average masses in Da (MH).












PA1001 pBMDL5 (nisABTC) Fully modified prenisin 5688.9 5820.0 5688.8
5820.3
Unmodified prenisin 5836.3 5964.0 5832.8
NZ9000 pBMDL8b (nisABT) Fully dehydrated S-6P, P-2L prenisin 5711.2 5846.1 5714.9
Unmodified prenisin 5857.0 5990.1 5858.9
NZ9000 pNGnisBT Leader peptide fused to angiotensin: 3186.5 3317.8 3186.6
pLP1ang 3317.9
Dehydrated 3169.2 3299.8 3168.6
3302.9
Dehydrated, ethanethiol addition 3235.6 3362.8 3231.6
Unmodified, (ethanethiol) 3188.6 3317.8 3186.6
NZ9000 pNGnisT Unmodified prenisin 5833.2 5964.0 5832.8
pNZnisA-E3
NZ9000 pNGnisT Unmodified prenisin C-terminally fused to enkephalin 6403.2 6535.6 6404.4
pNGenkT
NZ9000 pNGnisT Leader peptide fused to vasopressin 3405.2 3537.0 3405.8
pLP1vp
NZ9000 pNGnisT Leader peptide fused to angiotensin 3186.6 3317.8 3186.6
pLP1ang
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spectrometry (Fig. 3B). NisBT-expressing cells produced the
dehydrated prenisin with 8 dehydrated serine and threonine
residues; they also produced a fusion of leader peptide with
dehydrated angiotensin-(1–7) (Table II). This implies that bac-
teria that only contain LanBT (homologs of NisBT) or LanT and
the equivalent LanM part (the N-terminal dehydration domain
of LanM) can produce peptides with dehydro residues. There-
fore, two more amino acids are in principle available as build-
ing blocks for the synthesis of novel (poly)peptides with desired
properties. Dehydro residues have been reported to be essential
for the activity of some bioactive (poly)peptides (46–51). Al-
though the mechanism of NisB action is not known, statistical
studies on the variability of the flanking regions of the 8 dehy-
dratable serine and threonine residues in nisin and related
lantibiotics suggest that NisB, in contrast to the specific NisP,
is equipped with a broad substrate specificity. Engineering of
dehydro residues in nisin and Pep5 has been demonstrated
(3, 52). Therefore, a wide variety of peptides with dehydro
residues might be produced and exported via NisBT. In this
context, it is interesting to note that prePep5 fragments with
dehydrated residues of Pep5 are exported (53) when the pepC
gene is largely deleted. However, those studies all concern
original lantibiotics, and it would be of interest to introduce
such residues in peptides that are normally not modified.
Lantibiotic transporters are generally considered to export
only specific lantibiotics synthesized by the gene products
encoded in the same operon structure. Also, some nisin-
subtilin chimeras are exported (54), whereas nisin Z export
can be directed by the subtilin leader peptide (55). Those
studies, however, all pointed at a rather narrow substrate
specificity. Here we demonstrate that the specificity of the
NisT transporter is much wider than originally anticipated.
Various unrelated peptides, in either a modified form (in the
presence of NisB) or an unmodified form (in the absence of
NisB), can be secreted provided that they are fused to the
leader peptide.
Previous attempts to demonstrate functionally active NisP
upon overproduction in L. lactis have not been conclusive (4).
Here we show that, in the absence of other lantibiotic enzymes,
NisP can be functionally expressed in L. lactis. The enzyme
shows a clear leader peptidase activity on fully modified pre-
nisin. These data furthermore demonstrate that the NisP ac-
tivity is not coupled to the transport step by NisT. This agrees
with observations that extracellularly added fully modified pre-
nisin is processed by L. lactis NZ9800 (4). Remarkably, neither
the dehydrated prenisin nor the leader peptide fusions were
cleaved by NisP. This strongly suggests that the leader pep-
tidase is specific for thioether ring-containing prenisin. In
this respect, the dehydrated prenisin became a substrate for
NisP after pH-induced ring closure, which is very suggestive
of region and stereospecific closure of one or more rings.
Using model peptides, non-enzymatic, stereospecific ring clo-
sure has been shown for ring B (36, 37) and ring E (37) of
nisin, whereas region specificity and a three-to-one stereo
preference was shown for ring A of subtilin (37). These data
indicate that production of dehydro residue-containing pep-
tides may be followed by extracellular specific ring closure,
e.g. at pH 8.0.
Thioether rings are essential for most lantibiotic activities.
The opening of ring A or C (9) or replacement of a thioether ring
by a disulfide bridge and reducing it (56) causes a severe loss of
activity. In addition, the rings can protect (poly)peptides
against proteolytic degradation (3, 4), and their presence may
modulate the activity of peptides (2). Active lanthionine ana-
logs of somatostatin and enkephalin have been synthesized
chemically (2, 57), but this involved elaborate methods that
more easily could be performed by a fermentative route. The
transport by NisT of medically relevant therapeutic peptides
like enkephalin, vasopressin, and dehydrated angiotensin
(variants) compel further research on modifying such peptides
by the lantibiotic enzymes.
Summarizing, we have shown that NisBT is sufficient to
dehydrate and export the dehydrated non-lantibiotic angio-
tensin-(1–7) and the dehydrated prenisin and that the NisT
transporter is equipped with a wide substrate specificity, trans-
porting various peptides provided they are fused to the nisin
leader peptide. Production of peptides via NisBT provides an
adequate system to study the substrate specificity of NisB and
may enable the synthesis and export of a wide variety of pep-
tides with dehydro residues. This process can then be followed
by extracellular stereospecific ring closure to avoid possible
export incompatibilities of bulky thioether ring-containing
peptides.
Acknowledgments—Karin Scholtmeijer, Hans Hektor, and George T.
Robillard are gratefully acknowledged for help and helpful discussions.
TABLE III
The leader peptidase is specific for thioether ring containing prenisin
Cleavage of peptides by NisP was measured by MALDI-TOF MS. NisP was expressed by the peptide-producing cells, or cells expressing NisP
were added or, in control experiments, no NisP was present. By incubating for 1 h at pH 8.0, thioether ring closure in dehydrated prenisin was
induced. Theoretical values are average masses in Da (MH).
L. lactis













NZ9000 pLP1vp  pNGnisTP Leader peptide-vasopressin 2352.6 3405.8
1072.2
NZ9000 pLP1ang  pNGnisTP Leader peptide-angiotensin 3187.1 2352.6 3186.6
853.0
NZ9000 pNZnisA-E3  pNGnisTP Unmodified prenisin 5836.3 2352.6 5832.8
3499.2
NZ9000 pBMDL8b (nisABT) NZ9000/pNGnisTP cells Dehydrated S-6P, P-2L prenisin 5714.9 2378.7 5714.9
3355.2
NZ9000 pBMDL8b (nisABT) pH 8.0 and NZ9000/pNGnisTP
cells
Dehydrated S-6P, P-2L prenisin




PA1001 pBMDL5 (nisABTC) pH 8.0 Fully modified prenisin 5686.3 2352.6 5688.8
3355.2
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